Original Research

Phase II trial of second-line erlotinib and digoxin for nonsmall cell lung cancer (NSCLC)

Fadi Kayali, Muhamad A Janjua, Damian A Laber, Donald Miller, Goetz H Kloecker

Open Access Journal of Clinical Trials 2011, 3:9-13

Published Date: 6 February 2011